Geron (GERN) EBT Margin (2010 - 2026)
Geron's (GERN) quarterly EBT Margin came in at 29.0% in Q2 2026, up 427.0% year-over-year from 5.5% in Q2 2025, and down 321.37% quarter-over-quarter from 6.88% in Q1 2026.
Analysis
Geron (GERN) EBT Margin (2010 - 2026) Analysis & Trends
Geron has disclosed EBT Margin across 17 years of filings, most recently posting 29.0% for Q2 2026.
- In Q2 2026, EBT Margin rose 427.0% year-over-year to 29.0%; the TTM figure through Jun 2026 stood at 27.6% (up 2104.0% YoY), while the FY2025 annual figure was 37.26%, up 15580.0% from the prior year.
- EBT Margin came in at 29.0% for Q2 2026 at Geron, down from 6.88% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 6.88% in Q1 2026 to a low of 226147.83% in Q4 2023.
- Average EBT Margin over 5 years is 41735.56%, with a median of 10704.04% recorded in 2024.
- Year-over-year, EBT Margin slumped 18467113 bps in 2023 and jumped 22610847 bps in 2024.
- Over 5 years, EBT Margin stood at 41476.7% in 2022, then plunged by 445 bps to 226147.83% in 2023, then soared by 100 bps to 39.35% in 2024, then grew by 16 bps to 33.0% in 2025, then grew by 12 bps to 29.0% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 29.0% in Q2 2026, 6.88% in Q1 2026, and 33.0% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 27.53% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -131.41% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 41.75% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 35.61% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 35.78% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -528.97% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 13.77% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 4.84% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -20,427.46% |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | -29.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.00% |
| Mar 31, 2026 | -6.88% |
| Dec 31, 2025 | -33.00% |
| Sep 30, 2025 | -38.68% |
| Jun 30, 2025 | -33.27% |
| Mar 31, 2025 | -49.88% |
| Dec 31, 2024 | -39.35% |
| Sep 30, 2024 | -93.33% |
| Jun 30, 2024 | -7,632.65% |
| Mar 31, 2024 | -18,200.00% |
| Dec 31, 2023 | -226,147.83% |
| Sep 30, 2023 | -27,264.02% |
| Jun 30, 2023 | -169,710.34% |
| Mar 31, 2023 | -181,719.05% |
| Dec 31, 2022 | -41,476.70% |
| Sep 30, 2022 | -13,775.42% |
| Jun 30, 2022 | -40,036.99% |
| Mar 31, 2022 | -24,953.66% |
| Dec 31, 2021 | -3,077.98% |
| Sep 30, 2021 | -24,422.02% |